Trial · NCT04622735
Outcomes18
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 18 of 18
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Ranked Endpoints : 1. Sum of Pain Intensity Differences at 6 Hours (SPID0-6h) | 6 hours post-dose | score on a scale | MEAN | |
| PRIMARY | Total Pain Relief at 6 Hours (TOTPAR0-6h) | 6 hours post-dose | score on a scale | MEAN | |
| PRIMARY | Proportion of Responder Patients | 6 hours post-dose | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | The Patient's Global Impression of Change (PGIC) Questionnaire | 6 hours post-dose | Participants | COUNT_OF_PARTICIPANTS | |
| PRIMARY | The Onset of Pain Relief | during the first 6 hours | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Total Pain Relief at 1 Hour (TOTPAR0-1h), 2 Hours (TOTPAR0-2h), 3 Hours (TOTPAR0-3h), and 4 Hours (TOTPAR0-4h) | At 1 hour, 2 hours, 3 hours, and 4 hours | score on a scale | MEAN | |
| SECONDARY | Sum of Pain Intensity Differences at 1 Hour (SPID0-1h), 2 Hours (SPID0-2h), 3 Hours (SPID0-3h), and 4 Hours (SPID0-4h) | At 1 hour, 2 hours, 3 hours, and 4 hours | score on a scale | MEAN | |
| SECONDARY | The Pain Intensity Differences (PID) Assessment | At each timepoint: 30min, At 45min, until at 360 min post-dose | units on a scale | MEAN | |
| SECONDARY | Proportion of Responder Patients. | At 1 hour, 2 hours, 3 hours and 4 hours. | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Time to the Second Investigational Medicinal Product (IMP) Intake | Up to 5 days after first dose | minutes | MEDIAN | |
| SECONDARY | Participant Having Taken a Rescue Analgesic Treatment | Up to 10 days after first dose | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | Sum of Pain Intensity Differences | At days 1, 2, 3, 4 and 5 | score on a scale | MEAN | |
| SECONDARY | Proportion of Patients Having Taken a Rescue Analgesic Treatment Throughout the Study. | Up to 10 days after first dose | Participants | COUNT_OF_PARTICIPANTS | |
| SECONDARY | The Total Dose of Rescue Medication Taken. | Up to 10 days after first dose | mg | MEAN | |
| SECONDARY | Mean Duration Under Rescue Medication Over the 5 Days. | Up to 5 days after first dose | hours | MEAN | |
| SECONDARY | Number of Investigational Medicinal Product (IMP) Intakes | Up to 5 days after first dose | intake | MEAN | |
| SECONDARY | Patient's Global Impression of Change (PGIC) Score | Up to 10 days after first dose | Participants | COUNT_OF_PARTICIPANTS | |
| OTHER_PRE_SPECIFIED | Occurrence of Adverse Events (Serious and Non-serious Adverse Events). | Up to 10 days after first dose | All population has been analysed | Adverse Event | NUMBER |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04622735/outcomes